United States · Biotech startup

InnaMed

InnaMed's HomeLab device and software take the hassle out of blood testing and let you access precision medical care from the comfort and privacy of your home.

Funding reportedLast round: Venture - Series Unknown

BiotechPhiladelphia, United States

About InnaMed

InnaMed's HomeLab device and software take the hassle out of blood testing and let you access precision medical care from the comfort and privacy of your home.

Healthcare providers and researchers can now receive timely clinical reports that they are accustomed to interpreting directly to their EMR, LIMS or EDC system. Trend identification and pattern matching software can guide decision making in the prescription and dosing of therapy and deep integration with the healthcare system and telehealth services allows for data driven care while also ensuring human connection.

What company datasets say InnaMed raised

Funding, as reported

Reported in all$1.8Min dollars
Rounds7
Last roundVenture - Series Unknown
Last round dateMay 2021
Y CombinatorW17

Funding filed with regulators

InnaMed filed one raise, $1.1M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Aug 2019$1.1MotherCrowdfunding

On a portfolio page

Investors who name them

Each firm lists InnaMed on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Is this your company?

Add your raise, your deck and your story, and put InnaMed in front of investors. Or tell us what we have wrong.

List your startupSend a correction